Vera Therapeutics, Inc. (NASDAQ: VERA) reported Q2 EPS of ($1.20), $0.38 worse than the analyst estimate of ($0.82).

For earnings history and earnings-related data on Vera Therapeutics, Inc. (VERA) click here.